News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Annovation Adds $8 Million to Develop Safer, More Precise Anesthesia


9/10/2012 7:36:55 AM

Annovation BioPharma is announcing today that it has raised $8 million in a Series A funding to put toward the development of new therapies for anesthesia and critical care. The money comes from return seed investors, Cambridge, MA-based Atlas Venture and Partners Innovation Fund, as well as new strategic investor The Medicines Company (NASDAQ: MDCO). The round could hit a total of $11 million through additional investments from the syndicate, and will go toward pre-clinical and clinical development of Annovation’s technology, which is designed to administer anesthesia more safely and more precisely to patients than traditional methods, according to the release.

Read at Xconomy
Read at Mass High Tech

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES